Calcium gluconate

Chemical formula: C₁₂H₂₂CaO₁₄  Molecular mass: 430.372 g/mol  PubChem compound: 9290

Therapeutic indications

Calcium gluconate is indicated for:

Acute hypocalcaemia

Population group: only adults (18 years old or older)

Hypocalcemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Fluoride poisoning, lead poisoning

Population group: only adults (18 years old or older)

at least one of
Fluorosis
Saturnine poisoning

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cardiac resuscitation

Population group: only adults (18 years old or older)

Cardiac resuscitation

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hypocalcaemic tetany

Population group: only adults (18 years old or older)

Hypocalcaemic tetany

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Neonatal tetany

Population group: only newborns (0 - 40 days old)

Neonatal hypocalcemic tetany

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteoporosis

Population group: only adults (18 years old or older)

Osteoporosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Osteomalacia

Population group: only adults (18 - 65 years old)

Osteomalacia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Calcium gluconate is contraindicated in the following cases:

Cardiac glycosides

Cardiac glycosides

Severe renal failure

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Hypercalcaemia, hypercalciuria, hyperparathyroidism, hypervitaminosis D, bone metastasis, immobilisation osteoporosis

at least one of
Hypercalcemia
Hypercalciuria
Hyperparathyroidism
Hypervitaminosis D
Secondary malignant neoplasm of bone
Sarcoidosis

Ceftriaxone

Population group: only newborns (0 - 40 days old)

Ceftriaxone

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: CALCIUM GLUCONATE Sterile injection
Summary of Product Characteristics (SPC) 2019: EFFERVESCENT Uncoated tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈